NewcelX Ltd (NCEL)

• Market cap: $9.25M
• 1 day: -6.4%
• 5 days: -24%
• 1 month: -48.65%
• 3 months: -89.62%
• 6 months: -93.45%
• Year to date: -91.28%
• 1 year: -91%
• 5 years: -99.84%
• 10 years: -99.84%
• Sector: Healthcare
• Industry: Biotechnology

About: NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Employees: 11